CORONA REMEDIES LIMITED (CORONA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas.[1]
Corona Remedies Limited
CORONA
ROE29.5%
ROCE33.3%
Stock P/E62.8
Book Value₹122
Face Value₹10.0
High / Low₹2,124/1,337
Market Cap₹12,538Cr.
Current Price₹2,050
Dividend Yield0.47%
Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 17 July 2026 at 12:37:27